Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 3, 2008, Pages 686-694

  Szuster Ciesielska, Agnieszka ^a   Słotwińska, Maria ^a   Stachura, Anna ^a   Marmurowska Michałowska, Halina ^b   Dubas Ślemp, Halina ^b   Bojarska Junak, Agnieszka ^b   Kandefer Szerszeń, Martyna ^a  

^a MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

bax; bcl 2; Fas; Major depression; Oxidative stress

Indexed keywords

INTERLEUKIN 6; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOMETRY; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMORPHONUCLEAR CELL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADULT; ANALYSIS OF VARIANCE; ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CATALASE; CYTOCHROMES C; CYTOKINES; DEPRESSIVE DISORDER, MAJOR; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; HYDROGEN PEROXIDE; LEUKOCYTES; MALE; MIDDLE AGED; OXIDATIVE STRESS; PEROXIDASE; PROTO-ONCOGENE PROTEINS C-BCL-2; STATISTICS, NONPARAMETRIC; SUPEROXIDES;

EID: 39749149696     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.11.012     Document Type: Article

References (42)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), American Psychiatric Press, Washington, DC
2. Andersen H.R., Nielsen J.B., Nielsen F., and Grandjean P. Antioxidative enzyme activities in human erythrocytes. Clin Chem 43 (1997) 256-268
3. Arnold R., Shi J., Murad E., Whalen A.M., Sun C.Q., Polavaropu R., et al. Hydrogen peroxide mediates the cell growth and transformation caused by mitogenic oxidase Nox1. Proc Natl Acad Sci USA 98 (2001) 5550-5555
4. Bekaroglu M., Deger O., Karahan S.C., Bilici M., Soylu C., and Orem A. Effects of antidepressant treatment on polymorphonuclear elastase levels in patients with depression. J Affect Disord 59 (2000) 175-182
5. Bijl M., Horst G., Limburg P.C., and Kallenberg C.G. Effects of smoking on activation markers, Fas expression and apoptosis of peripheral blood lymphocytes. Eur J Clin Investig 31 (2001) 550-553
6. Bilici M., Efe H., Koroglu M.A., Uydu H.A., Bekaroglu M., and Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 64 (2001) 43-51
7. Bohus M., Forstner U., Kiefer C., Gebicke-Harter P., Timmer J., Spraul G., et al. Increased sensitivity of the inositol-phospholipid system in neutrophils from patients with acute major depressive episodes. Psych Res 65 (1996) 45-51
8. Clairborne A.C., and Fridovich I. Chemical and enzymatic intermediates in the peroxidation of o-dianisidin by horseradish peroxidase. Biochemistry 18 (1979) 23-24
9. Connor T.J., and Leonard B.E. Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci 62 (1998) 583-606
10. Corrigan F.M. Depression: immunological resignation of the will to live?. Med Hypotheses 50 (1998) 9-18
11. Domagala-Kulawik J., Hoser G., Dabrowska M., and Chazan R. Increased proportion of Fas positive CD8+ cells in peripheral blood of patients with COPD. Respir Med 101 (2007) 1338-1343
12. Eilat E., Mendlovic S., Doron A., Zakuth V., and Spirer Z. Increased apoptosis in patients with major depression: a preliminary study. J Immunol 163 (1999) 533-534
13. Fanning N.F., Redmond H.P., and Bouchier-Hayes D. Neutrophils and apoptosis. In: Gabrilovich D. (Ed). The neutrophils: new outlook for old cells (1999), Imperial College Press, London 231-242
14. Frank M.G., Hendricks S.E., Bessete D., Johnson D.R., Wieseler F.J.L., and Burke W.J. Levels of monocyte reactive oxygen species are associated with reduced natural killer cell activity in major depressive disorder. Neuropsychobiology 44 (2002) 1-6
15. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-61
16. Inglot A., Leszek J., Piasecki E., and Sypuła A. Interferon responses in schizophrenia and major depressive disorders. Biol Psychiatry 35 (1994) 464-473
17. Khanzode S.D., Dakhale G.N., Khanzode S.S., Saoji A., and Palasodkar R. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep 8 (2003) 365-370
18. Kogut M.H., Genovese K.J., and Lowry V.K. Differential activation of signal transduction pathways mediating phagocytosis, oxidative burst, and degranulation by chicken heterophiles in response to stimulation with opsonized Salmonella enteritidis. Inflammation 25 (2001) 7-15
19. Kornsmeyer S.J. Regulators of cell death. Trends Genet 11 (1995) 101-110
20. Kubera M., Kenis G., Bosmans E., Zieba A., Dudek D., Nowak G., et al. Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission. Pol J Pharmacol 52 (2000) 237-241
21. Kuloglu M., Atmaca M., Tezcan E., Gecici O., Tunckol H., and Ustundag B. Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorders. Neuropsychobiology 46 (2002) 27-32
22. Maes M., Meltzer H.Y., Bosmans E., Bergmans R., Vandoolaeghe E., Ranjan R., et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferring receptor in major depression. J Affect Disord 34 (1995) 301-309
23. Maes M., De Vos N., Pioli R., Demendts P., Wauters A., Neels H., et al. Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness. J Affect Disord 58 (2000) 241-246
24. Maianski N.A., Roos D., and Kuijpers T.W. Tumor necrosis factor alpha induces a caspase-independent death pathway in human neutrophils. Blood 101 (2003) 1987-1995
25. Mayo L.A., and Curnutte J.T. Kinetic microplate assay for superoxide production by neutrophils and other phagocytic cells. Methods Enzymol 186 (1990) 571-575
26. Mikova O., Yakimova R., Bosmans E., Kenis G., and Maes M. Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur Neuropsychopharmacol 11 (2001) 203-208
27. Nowak G., Nowak M., Matuszewska A., and Malarczyk E. Activities of selected oxidases in idiophasic cultures of Trametes versicolor and Pleurotus eryngii. Biol Sci Symp (1997) 397-400
28. Oberley L.W., and Spitz D.R. Assay of superoxide dismutase activity in tumor tissue. Methods Enzymol 105 (1984) 457-464
29. Oltvai Z.N., Millman C.L., and Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74 (1993) 609-613
30. Osborne B.A. Apoptosis and the maintenance of homeostasis in the immune system. Curr Opin Immunol 8 (1996) 245-247
31. Owen B.M., Eccleston D., Ferrier I.N., and Young A.H. levels of plasma IL-1 beta in major and postviral depression. Acta Psychiatr Scand 103 (2001) 161-162
32. Pick E. Microassays for superoxide and hydrogen peroxide production and nitroblue tetrazolium reduction using and enzyme immunoassay microplate reader. Methods Enzymol 32 (1986) 414-419
33. Pifferi P.G., Lanserini G., and Biancani M. Glucose oxidase determination by means of the formation of the hydrogen peroxide-titanium complex. Ann Chim 18 (1981) 729
34. Robertson M.J., Schacterle R.S., Mackin G.A., Wilson S.N., Bloomingdale K.L., Ritz J., et al. Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression. Clin Exp Immunol 141 (2005) 326-332
35. Sarandol A., Sarandol E., Eker S.S., Karaagac E.U., Hizli B.Z., Dirican M., et al. Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 30 (2006) 1103-1108
36. Sarandol A., Sarandol E., Eker S.S., Erdinc S., Vatansever E., and Kirli S. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol 22 (2007) 67-73
37. Sato E.F., Higashino M., Ikeda K., Ryotaro W., Matsuo M., Utsumi K., et al. Oxidative stress-induced death of human oral neutrophils. Am J Physiol Cell Physiol 284 (2003) C1048-C1053
38. Służewska A., Rybakowski J., Sobieska M., and Wiktorowicz K. Concentrations and microheterogeneity glycophorms of alpha-1-acid glycoprotein in major depression. J Affect Disord 39 (1996) 149-155
39. Srivastava N., Barthwal M.K., Dallal P.K., Agarwal A.K., Nag D., Seth P.K., et al. A study on nitric oxide, beta-adrenergic receptors and antioxidant status in the polymorphonuclear leukocytes from patients of depression. J Affect Disord 72 (2002) 45-52
40. Sulowska Z., Majewska E., Krawczyk K., Klink M., and Tchórzewski H. Influence of opioid peptides on human neutrophil apoptosis and activation in vitro. Med Inflam 11 (2002) 245-250
41. Suwa T., Hogg J.C., English D., and van Eeden S.F. Interleukin-6 induces demargination of intravascular neutrophils and shortens their transit in marrow. Am J Physiol Heart Circ Physiol 279 (2000) H2954-H2960
42. Suwa T., Hogg J.C., Quinlan K.B., and van Eeden S.F. The effect of interleukin-6 on lectin levels on polymorphonuclear leukocytes. Am J Physiol Heart Circ Physiol 283 (2002) H879-H884